Literature DB >> 15802108

[New perspectives for the treatment of diabetes mellitus].

P Roura Olmeda, M Mata Cases, J F Cano Pérez.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15802108      PMCID： PMC7684410          DOI： 10.1157/13072785

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  9 in total

Review 1.  Oral antihyperglycemic therapy for type 2 diabetes: scientific review.

Authors:  Silvio E Inzucchi
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

Review 2.  Combination therapies with insulin in type 2 diabetes.

Authors:  H Yki-Järvinen
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

3.  Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.

Authors:  M Hanefeld; M Cagatay; T Petrowitsch; D Neuser; D Petzinna; M Rupp
Journal:  Eur Heart J       Date:  2004-01       Impact factor: 29.983

Review 4.  [Criteria and guidelines for combined therapy of type 2 diabetes. 2004 consensus document].

Authors:  Alberto Goday Arno; Josep Franch Nadal; Manuel Mata Cases
Journal:  Med Clin (Barc)       Date:  2004-07-03       Impact factor: 1.725

5.  The implementation of nutritional advice for people with diabetes.

Authors:  H Connor; F Annan; E Bunn; G Frost; N McGough; T Sarwar; B Thomas
Journal:  Diabet Med       Date:  2003-10       Impact factor: 4.359

6.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

7.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Authors:  Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2003-01-30       Impact factor: 91.245

8.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.